Biochemist Seeks New Drug Treatment for COVID-19 Patients
Cal State Fullerton biochemist Stevan Pecic is launching a scientific research project to identify and develop a new therapeutic drug for COVID-19 patients with acute respiratory distress syndrome, a life-threatening lung condition developed by some seriously ill with the new coronavirus.